In particular, the presence of SARS-CoV-2-specific IFN-γ-producing CD4+ T helper (Th)1 cells and CD8+ cytotoxic T lymphocytes was associated with reduced disease severity, while CD4+ and CD8+ T-cell lymphopenia was revealed in severe COVID-19 cases [3]. The gene discussed is CD4; the disease is COVID-19.